These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4453617)

  • 1. Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances.
    Vargaftig BB; Tranier Y; Chignard M
    Prostaglandins; 1974 Oct; 8(2):133-56. PubMed ID: 4453617
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.
    Vargaftig BB; Zirinis P
    Nat New Biol; 1973 Jul; 244(134):114-6. PubMed ID: 4517254
    [No Abstract]   [Full Text] [Related]  

  • 3. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
    Vargaftig BB; Chignard M
    Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade by metal complexing agents and by catalase of the effects of arachidonic acid on platelets: relevance to the study of anti-inflammatory mechanisms.
    Vargaftig BB; Tranier Y; Chignard M
    Eur J Pharmacol; 1975 Aug; 33(1):19-29. PubMed ID: 1175685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C.
    Ferreira SH; Vargaftig BB
    Br J Pharmacol; 1974 Apr; 50(4):543-51. PubMed ID: 4155653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid.
    Chignard M; Vargaftig B
    Eur J Pharmacol; 1976 Jul; 38(1):7-18. PubMed ID: 954835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction.
    Raz A; Minkes MS; Needleman P
    Biochim Biophys Acta; 1977 Aug; 488(2):305-11. PubMed ID: 560869
    [No Abstract]   [Full Text] [Related]  

  • 8. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet adhesion to aortic subendothelium by indomethacin--an effect unrelated to inhibition of arachidonic acid metabolism.
    Menys VC; Davies JA
    Thromb Res; 1985 Jan; 37(1):225-9. PubMed ID: 3920777
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in pharmacological receptor activities of rabbit arteries by sulfhydryl reagents.
    Asano M; Hidaka H
    Jpn J Pharmacol; 1983 Feb; 33(1):227-40. PubMed ID: 6876518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid-induced human platelet aggregation and prostaglandin formation.
    Silver MJ; Smith JB; Ingerman C; Kocsis JJ
    Prostaglandins; 1973 Dec; 4(6):863-75. PubMed ID: 4205973
    [No Abstract]   [Full Text] [Related]  

  • 12. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.
    Willis AL; Vane FM; Kuhn DC; Scott CG; Petrin M
    Prostaglandins; 1974 Dec; 8(6):453-507. PubMed ID: 4471695
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Arachidonic acid and platelet aggregation.
    Furlow TW
    Lancet; 1974 Nov; 2(7888):1080. PubMed ID: 4138267
    [No Abstract]   [Full Text] [Related]  

  • 14. Rabbit-aorta contracting substance (RCS) may be a prostaglandin precursor.
    Gryglewski R; Vane JR
    Br J Pharmacol; 1971 Oct; 43(2):420P-421P. PubMed ID: 5158211
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of exogenous and endogenous prostacyclin on the contractility of rabbit splenic capsular smooth muscle.
    Simmet T; Förstermann U; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):245-53. PubMed ID: 6995863
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Fat mobilisation and platelet aggregation.
    Vincent JE
    Lancet; 1975 Apr; 1(7910):799-800. PubMed ID: 48021
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of arachidonic acid, prostaglandin E2 and prostaglandin F2alpha on the longitudinal stomach strip of the rat.
    Splawinski JA; Nies AS; Sweetman B; Oates JA
    J Pharmacol Exp Ther; 1973 Dec; 187(3):501-10. PubMed ID: 4203719
    [No Abstract]   [Full Text] [Related]  

  • 18. Some biological effects of prostaglandin endoperoxide analogs.
    Malmsten C
    Life Sci; 1976 Jan; 18(2):169-76. PubMed ID: 1256232
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (Wy-23,049)--comparison with acetylsalicylic acid.
    Fenichel RL; Dougherty JA; Alburn HE
    Biochem Pharmacol; 1974 Dec; 23(23):3273-82. PubMed ID: 4374215
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
    Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
    Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.